BeiGene
BGNE
#955
Rank
โ‚ฌ18.64 B
Marketcap
170,45ย โ‚ฌ
Share price
0.49%
Change (1 day)
5.82%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Unfortunately we have no cost to borrow data for this company